Nektar Therapeutics Stock Market Value
| NKTR Stock | USD 1.19 0.02 1.71% |
| Symbol | Nektar |
Nektar Therapeutics Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nektar Therapeutics. If investors know Nektar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nektar Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.89) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
The market value of Nektar Therapeutics is measured differently than its book value, which is the value of Nektar that is recorded on the company's balance sheet. Investors also form their own opinion of Nektar Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Nektar Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nektar Therapeutics' market value can be influenced by many factors that don't directly affect Nektar Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nektar Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nektar Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nektar Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Nektar Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nektar Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nektar Therapeutics.
| 01/13/2024 |
| 01/07/2025 |
If you would invest 0.00 in Nektar Therapeutics on January 13, 2024 and sell it all today you would earn a total of 0.00 from holding Nektar Therapeutics or generate 0.0% return on investment in Nektar Therapeutics over 360 days. Nektar Therapeutics is related to or competes with Assembly Biosciences, Spero Therapeutics, Achilles Therapeutics, Instil Bio, CytomX Therapeutics, NextCure, and Nuvation Bio. Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medi... More
Nektar Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nektar Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nektar Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 17.45 | |||
| Value At Risk | (8.55) | |||
| Potential Upside | 6.36 |
Nektar Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nektar Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nektar Therapeutics' standard deviation. In reality, there are many statistical measures that can use Nektar Therapeutics historical prices to predict the future Nektar Therapeutics' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.21) | |||
| Treynor Ratio | (0.11) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nektar Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Nektar Therapeutics Backtested Returns
Nektar Therapeutics has Sharpe Ratio of -0.0119, which conveys that the firm had a -0.0119% return per unit of risk over the last 3 months. Nektar Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nektar Therapeutics' Standard Deviation of 4.21, mean deviation of 3.13, and Risk Adjusted Performance of (0.01) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.04, which conveys a somewhat significant risk relative to the market. Nektar Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Nektar Therapeutics is expected to follow. At this point, Nektar Therapeutics has a negative expected return of -0.0514%. Please make sure to verify Nektar Therapeutics' information ratio, skewness, as well as the relationship between the Skewness and day typical price , to decide if Nektar Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.16 |
Insignificant reverse predictability
Nektar Therapeutics has insignificant reverse predictability. Overlapping area represents the amount of predictability between Nektar Therapeutics time series from 13th of January 2024 to 11th of July 2024 and 11th of July 2024 to 7th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nektar Therapeutics price movement. The serial correlation of -0.16 indicates that over 16.0% of current Nektar Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.16 | |
| Spearman Rank Test | -0.56 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Nektar Therapeutics lagged returns against current returns
Autocorrelation, which is Nektar Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Nektar Therapeutics' stock expected returns. We can calculate the autocorrelation of Nektar Therapeutics returns to help us make a trade decision. For example, suppose you find that Nektar Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Nektar Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Nektar Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Nektar Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Nektar Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Nektar Therapeutics Lagged Returns
When evaluating Nektar Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Nektar Therapeutics stock have on its future price. Nektar Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Nektar Therapeutics autocorrelation shows the relationship between Nektar Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Nektar Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Nektar Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nektar Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nektar Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Nektar Stock
| 0.84 | DNLI | Denali Therapeutics Buyout Trend | PairCorr |
| 0.63 | EVOK | Evoke Pharma | PairCorr |
| 0.81 | FOLD | Amicus Therapeutics | PairCorr |
| 0.85 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
Moving against Nektar Stock
| 0.77 | LFCR | Lifecore Biomedical | PairCorr |
| 0.66 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.47 | GILD | Gilead Sciences Sell-off Trend | PairCorr |
| 0.4 | IMCC | Im Cannabis Corp | PairCorr |
The ability to find closely correlated positions to Nektar Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nektar Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nektar Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nektar Therapeutics to buy it.
The correlation of Nektar Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nektar Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nektar Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nektar Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Nektar Stock Analysis
When running Nektar Therapeutics' price analysis, check to measure Nektar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nektar Therapeutics is operating at the current time. Most of Nektar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nektar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nektar Therapeutics' price. Additionally, you may evaluate how the addition of Nektar Therapeutics to your portfolios can decrease your overall portfolio volatility.